Study of Sirolimus in IgG4-related Disease

NCT05746689 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

IgG4-related Disease

Interventions

DRUG: Sirolimus

Sponsor

Peking University International Hospital